Logo image of VCEL

VERICEL CORP (VCEL) Stock Fundamental Analysis

NASDAQ:VCEL - Nasdaq - US92346J1088 - Common Stock - Currency: USD

37.655  +1.12 (+3.05%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to VCEL. VCEL was compared to 550 industry peers in the Biotechnology industry. VCEL scores excellent on profitability, but there are some minor concerns on its financial health. VCEL is growing strongly while it is still valued neutral. This is a good combination! These ratings could make VCEL a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

VCEL had positive earnings in the past year.
VCEL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VCEL reported negative net income in multiple years.
Each year in the past 5 years VCEL had a positive operating cash flow.
VCEL Yearly Net Income VS EBIT VS OCF VS FCFVCEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

With an excellent Return On Assets value of 1.63%, VCEL belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.32%, VCEL belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 0.24%, VCEL belongs to the best of the industry, outperforming 91.09% of the companies in the same industry.
Industry RankSector Rank
ROA 1.63%
ROE 2.32%
ROIC 0.24%
ROA(3y)-1.54%
ROA(5y)-1.26%
ROE(3y)-2.18%
ROE(5y)-1.76%
ROIC(3y)N/A
ROIC(5y)N/A
VCEL Yearly ROA, ROE, ROICVCEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

With an excellent Profit Margin value of 2.85%, VCEL belongs to the best of the industry, outperforming 91.45% of the companies in the same industry.
VCEL has a better Operating Margin (0.48%) than 90.91% of its industry peers.
VCEL has a Gross Margin of 73.47%. This is amongst the best in the industry. VCEL outperforms 82.91% of its industry peers.
In the last couple of years the Gross Margin of VCEL has remained more or less at the same level.
Industry RankSector Rank
OM 0.48%
PM (TTM) 2.85%
GM 73.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y1.27%
VCEL Yearly Profit, Operating, Gross MarginsVCEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCEL is destroying value.
The number of shares outstanding for VCEL has been increased compared to 1 year ago.
VCEL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for VCEL is higher compared to a year ago.
VCEL Yearly Shares OutstandingVCEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VCEL Yearly Total Debt VS Total AssetsVCEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

VCEL has an Altman-Z score of 8.30. This indicates that VCEL is financially healthy and has little risk of bankruptcy at the moment.
VCEL has a better Altman-Z score (8.30) than 84.55% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that VCEL is not too dependend on debt financing.
VCEL has a Debt to Equity ratio of 0.01. This is comparable to the rest of the industry: VCEL outperforms 44.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 8.3
ROIC/WACC0.02
WACC9.78%
VCEL Yearly LT Debt VS Equity VS FCFVCEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 4.97 indicates that VCEL has no problem at all paying its short term obligations.
VCEL has a Current ratio (4.97) which is comparable to the rest of the industry.
A Quick Ratio of 4.56 indicates that VCEL has no problem at all paying its short term obligations.
VCEL has a Quick ratio (4.56) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 4.97
Quick Ratio 4.56
VCEL Yearly Current Assets VS Current LiabilitesVCEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

8

3. Growth

3.1 Past

VCEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 864691128455134976.00%, which is quite impressive.
Measured over the past 5 years, VCEL shows a small growth in Earnings Per Share. The EPS has been growing by 3.71% on average per year.
VCEL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.13%.
VCEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.01% yearly.
EPS 1Y (TTM)864691128455134800%
EPS 3YN/A
EPS 5Y3.71%
EPS Q2Q%90%
Revenue 1Y (TTM)16.13%
Revenue growth 3Y14.95%
Revenue growth 5Y15.01%
Sales Q2Q%20.09%

3.2 Future

The Earnings Per Share is expected to grow by 72.81% on average over the next years. This is a very strong growth
VCEL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.96% yearly.
EPS Next Y38.83%
EPS Next 2Y105.64%
EPS Next 3Y96.26%
EPS Next 5Y72.81%
Revenue Next Year20.06%
Revenue Next 2Y22.26%
Revenue Next 3Y23%
Revenue Next 5Y24.96%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VCEL Yearly Revenue VS EstimatesVCEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
VCEL Yearly EPS VS EstimatesVCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

VCEL is valuated quite expensively with a Price/Earnings ratio of 313.79.
Compared to the rest of the industry, the Price/Earnings ratio of VCEL indicates a rather cheap valuation: VCEL is cheaper than 90.00% of the companies listed in the same industry.
VCEL is valuated expensively when we compare the Price/Earnings ratio to 26.73, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 49.47 indicates a quite expensive valuation of VCEL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VCEL indicates a rather cheap valuation: VCEL is cheaper than 89.45% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.61, VCEL is valued a bit more expensive.
Industry RankSector Rank
PE 313.79
Fwd PE 49.47
VCEL Price Earnings VS Forward Price EarningsVCEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

VCEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VCEL is cheaper than 90.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 177.53
VCEL Per share dataVCEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VCEL has a very decent profitability rating, which may justify a higher PE ratio.
VCEL's earnings are expected to grow with 96.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.08
PEG (5Y)84.5
EPS Next 2Y105.64%
EPS Next 3Y96.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VCEL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERICEL CORP

NASDAQ:VCEL (8/13/2025, 3:19:47 PM)

37.655

+1.12 (+3.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners111.03%
Inst Owner Change2.16%
Ins Owners1.04%
Ins Owner Change8.7%
Market Cap1.90B
Analysts87.14
Price Target54.95 (45.93%)
Short Float %10.74%
Short Ratio10.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.99%
Min EPS beat(2)-78.61%
Max EPS beat(2)68.63%
EPS beat(4)3
Avg EPS beat(4)16.25%
Min EPS beat(4)-78.61%
Max EPS beat(4)68.63%
EPS beat(8)6
Avg EPS beat(8)20.38%
EPS beat(12)8
Avg EPS beat(12)32.28%
EPS beat(16)8
Avg EPS beat(16)-1.68%
Revenue beat(2)0
Avg Revenue beat(2)-4.04%
Min Revenue beat(2)-4.23%
Max Revenue beat(2)-3.86%
Revenue beat(4)1
Avg Revenue beat(4)-2.16%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)2.84%
Revenue beat(8)2
Avg Revenue beat(8)-1.28%
Revenue beat(12)4
Avg Revenue beat(12)-0.41%
Revenue beat(16)5
Avg Revenue beat(16)-1.44%
PT rev (1m)-9.26%
PT rev (3m)-14.82%
EPS NQ rev (1m)-112.19%
EPS NQ rev (3m)-114.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-25.76%
Revenue NQ rev (1m)-8.57%
Revenue NQ rev (3m)-7.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 313.79
Fwd PE 49.47
P/S 7.61
P/FCF N/A
P/OCF 40.13
P/B 6.18
P/tB 6.3
EV/EBITDA 177.53
EPS(TTM)0.12
EY0.32%
EPS(NY)0.76
Fwd EY2.02%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.94
OCFY2.49%
SpS4.95
BVpS6.09
TBVpS5.98
PEG (NY)8.08
PEG (5Y)84.5
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 2.32%
ROCE 0.3%
ROIC 0.24%
ROICexc 0.34%
ROICexgc 0.35%
OM 0.48%
PM (TTM) 2.85%
GM 73.47%
FCFM N/A
ROA(3y)-1.54%
ROA(5y)-1.26%
ROE(3y)-2.18%
ROE(5y)-1.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y1.27%
F-Score7
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.17
Cap/Depr 667.96%
Cap/Sales 22.3%
Interest Coverage 250
Cash Conversion 496.85%
Profit Quality N/A
Current Ratio 4.97
Quick Ratio 4.56
Altman-Z 8.3
F-Score7
WACC9.78%
ROIC/WACC0.02
Cap/Depr(3y)649.08%
Cap/Depr(5y)464.88%
Cap/Sales(3y)15.17%
Cap/Sales(5y)10.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)864691128455134800%
EPS 3YN/A
EPS 5Y3.71%
EPS Q2Q%90%
EPS Next Y38.83%
EPS Next 2Y105.64%
EPS Next 3Y96.26%
EPS Next 5Y72.81%
Revenue 1Y (TTM)16.13%
Revenue growth 3Y14.95%
Revenue growth 5Y15.01%
Sales Q2Q%20.09%
Revenue Next Year20.06%
Revenue Next 2Y22.26%
Revenue Next 3Y23%
Revenue Next 5Y24.96%
EBIT growth 1Y131.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2048.47%
EBIT Next 3Y242.91%
EBIT Next 5Y172.93%
FCF growth 1Y-161.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.11%
OCF growth 3Y26.05%
OCF growth 5YN/A